Venture Life Group plc is an international consumer self-care company. The Company focuses on developing, manufacturing and commercializing products for the ageing population. Its segments include Brands, which includes sales of branded healthcare and cosmetics products direct to retailers and under distribution agreements, and Manufacturing, which includes sales of products and services under contract development and manufacturing agreements. Its product range includes the UltraDEX oral care range, which is primarily sold in the United Kingdom through the pharmacy and grocery retailers. Its product range also includes food supplements for lowering cholesterol and maintaining brain function, dermo-cosmetics for addressing the signs of ageing and medical devices for conditions, such as hemorrhoids, minor aches and pains, and women's intimate health issues. It also provides development and manufacturing services to other companies in the healthcare and skincare sectors.
Industry, Sector and Symbol:
- Market Cap: £22.29 million
- Outstanding Shares: 36,837,000
- 50 Day Moving Avg: GBX 67.48
- 200 Day Moving Avg: GBX 64.21
- 52 Week Range: GBX 40 - GBX 90
Sales & Book Value:
- Trailing P/E Ratio: N/A
- P/E Growth: 0.00
- Annual Revenue: £14.28 million
- Price / Sales: 1.56
- Book Value: GBX 0.39 per share
- Price / Book: 1.55
- EBIDTA: $504,999.00
- Net Margins: -4.41%
- Return on Equity: -4.95%
- Return on Assets: -2.64%
- Average Volume: 39,440 shs.
Frequently Asked Questions for Venture Life Group PLC (LON:VLG)
What is Venture Life Group PLC's stock symbol?
Venture Life Group PLC trades on the London Stock Exchange (LON) under the ticker symbol "VLG."
How often does Venture Life Group PLC pay dividends? What is the dividend yield for Venture Life Group PLC?
Venture Life Group PLC announced a dividend on Thursday, March 23rd. Stockholders of record on Thursday, May 25th will be given a dividend of GBX 0.04 per share on Friday, June 23rd. This represents a dividend yield of 0.06%. The ex-dividend date of this dividend is Thursday, May 25th. The official announcement can be viewed at this link. View Venture Life Group PLC's Dividend History.
When will Venture Life Group PLC make its next earnings announcement?
Where is Venture Life Group PLC's stock going? Where will Venture Life Group PLC's stock price be in 2017?
2 analysts have issued 12 month price targets for Venture Life Group PLC's shares. Their predictions range from GBX 128 to GBX 128. On average, they expect Venture Life Group PLC's stock price to reach GBX 128 in the next year. View Analyst Ratings for Venture Life Group PLC.
Who are some of Venture Life Group PLC's key competitors?
Some companies that are related to Venture Life Group PLC include Marinus Pharmaceuticals (MRNS), Histogenics Corporation (HSGX), BioLife Solutions (BLFS), Evoke Pharma (EVOK), Pernix Therapeutics Holdings (PTX), Immune Pharmaceuticals (IMNP), Eyegate Pharmaceuticals (EYEG), Galena Biopharma (GALE), Apricus Biosciences (APRI), Aegerion Pharmaceuticals (AEGR), Amryt Pharma PLC (FAST), CoLucid Pharmaceuticals (CLCD), Sagent Pharmaceuticals (SGNT), Shire PLC (SHPG), SkyePharma PLC (SKP), Theravance Biopharma (TBPHV), Valeant Pharmaceuticals Intl (BVF) and XenoPort (XNPT).
Who are Venture Life Group PLC's key executives?
Venture Life Group PLC's management team includes the folowing people:
- Jerry Randall, Chief Executive Officer, Executive Director
- Adrian Graham Crockett, Chief Financial Officer
- Gianluca Braguti, Executive Director, Manufacturing Director
- Sharon Collins, Executive Director, Commercial Director
- Lynn Drummond, Non-Executive Chairman of the Board
- Peter Edward Bream, Non-Executive Director
- John Sylvester, Non-Executive Director
How do I buy Venture Life Group PLC stock?
Shares of Venture Life Group PLC and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
What is Venture Life Group PLC's stock price today?
MarketBeat Community Rating for Venture Life Group PLC (LON VLG)MarketBeat's community ratings are surveys of what our community members think about Venture Life Group PLC and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.
One share of Venture Life Group PLC stock can currently be purchased for approximately GBX 60.50.
Consensus Ratings for Venture Life Group PLC (LON:VLG) (How are Consensus Ratings Calculated?)
MarketBeat calculates consensus ratings using the most recent rating from each brokerage that has rated a stock within the last twelve months. Since brokers often use different ratings systems, each rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings. Each stock's consensus rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months.
MarketBeat will no longer include ratings and price target data in its consensus calculation if a broker drops coverage and MarketBeat has received a report that coverage was dropped. Ratings from certain research firms that issue ratings using purely quantitative methods (such as Zacks, Vetr and ValuEngine) are not included in consensus calculations. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
|Ratings Breakdown: ||1 Hold Rating, 1 Buy Rating|
|Consensus Rating:||Buy (Score: 2.50)|
|Consensus Price Target: ||GBX 128|
Analysts' Ratings History for Venture Life Group PLC (LON:VLG)
(Data available from 7/26/2015 forward)
|7/19/2017||Northland Securities||Reiterated Rating||Corporate|
|4/20/2017||Panmure Gordon||Reiterated Rating||Buy||GBX 128|
|11/15/2016||Beaufort Securities||Reiterated Rating||Speculative Buy|
Earnings History for Venture Life Group PLC (LON:VLG)Earnings History by Quarter for Venture Life Group PLC (LON VLG)
(Data available from 1/1/2011 forward)
|Date||Quarter||Consensus Estimate||Actual EPS||Revenue Estimate||Actual Revenue||Release Link||Conference Call||Details|
Earnings Estimates for Venture Life Group PLC (LON:VLG)
Current Year EPS Consensus Estimate: $-3.30 EPS
Dividend History by Quarter for Venture Life Group PLC (LON VLG)
(Data available from 1/1/2013 forward)
|Announced||Period||Amount||Yield||Ex-Dividend Date||Record Date||Payable Date|
Insider Trading History for Venture Life Group PLC (LON:VLG)
No insider trades for this company have been tracked by MarketBeat.com
Headline Trends for Venture Life Group PLC (LON:VLG)
Latest Headlines for Venture Life Group PLC (LON:VLG)
Venture Life Group PLC (VLG) Chart for Wednesday, July, 26, 2017